Consolidated Balance Sheet - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Assets, Current
Cash and Cash Equivalents, at Carrying Value	$ 948	$ 164
Inventory	19,174	19,174
Total current assets	20,122	19,338
TOTAL ASSETS	20,122	19,338
Current Liabilities
Accounts payable and accrued liabilities	18,928	17,326
Due to related party	183,862	150,833
Total current liabilities	202,790	168,159
Stockholders' Equity
Preferred stock authorized 10,000,000 shares, par value $.001, issued and oustanding 0 shares.
Common stock authorized 290,000,000 shares, par value $.001, issued and oustanding 241,377,179 shares as of March 31, 2021 and December 31, 2020	241,377	241,377
Common stock issuable	27,000	27,000
Additional paid-in capital	3,136,382	3,136,382
Accumulated deficit	(3,587,427)	(3,553,580)
Total stockholders' equity	(182,668)	(148,821)
Total liabilities and stockholders' equity	$ 20,122	$ 19,338

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.